Cell-based therapy for management of osteoarthritis
10.3867/j.issn.1000-3002.2017.10.100
- Author:
ZHAO YING-JIE
1
;
CHANG YAN
;
WEI WEI
Author Information
1. Institute of Clinical Pharmacology
- Keywords:
mesenchymal stem cells;
osteoarthritis;
cell therapy;
cartilage repair
- From:
Chinese Journal of Pharmacology and Toxicology
2017;31(10):1015-1015
- CountryChina
- Language:Chinese
-
Abstract:
Absrtact: Osteoarthritis (OA) is a most common form of degenerative joint disease, primarily characterized by the degradation of articular cartilage, subchondral sclerosis and inflammation of the synovial membrane. Mesenchymal stem cells (MSCs), a multipotent adult stem cell population, can be isolated from many connective tissue lineages, including those of the diarthrodial joint. Joint-resident MSCs or MSC-like progenitor cells contribute to the maintenance of healthy microenvironment or to the response to trauma. The onset of degenerative changes in the joint related to abnormal condition or depletion of these endogenous MSCs and native host hyaline cartilage cells, leading to limited self-repair potential of the joint and advance of the degradation. To date, no acknowledged medical treatment strategies, including non-operative and classical surgical techniques, are efficient in restoring normal anatomy and function of hyaline cartilage in OA. This highlights an urgent need for better celled-based therapeutic strategies that supplement these functional cells exogenously to recover the tissue homeostasis and repair in joint cavity via chondrogenic and anti- in fl ammatory functions. In this review we focus on the role of native MSCs in healthy or OA joint and recent progress in cell-based researches utilizing culture-expanded chondrocytes, pluripotent stem cells, or MSCs from different sources for treating OA.
